Back to Results
First PageMeta Content
Nutrition / Lipids / Omega-3 fatty acid / Treatment of bipolar disorder / Docosahexaenoic acid / Health sciences / Fish oil / Dietary supplement / Polyunsaturated fat / Fatty acids / Medicine / Health


November 17, 2014 VIA ELECTRONIC SUBMISSION Food and Drug Administration, Office of Nutritional Products, Labeling and Dietary Supplements (HFS[removed]Paint Branch Pkwy
Add to Reading List

Document Date: 2014-11-17 11:16:06

Open Document

File Size: 184,25 KB

Share Result on Facebook

City

Washington / D.C. / /

Country

United States / /

IndustryTerm

Treatment of High Blood Pressure / functional food manufacturers / healthcare community / healthcare professionals / products / krill oil / natural food stores / efficacious products / functional food ingredients / food component / fish oil / large portion / manufacturing / fish oil supplementation / flax seed oil / food labeling / food / /

MedicalCondition

hypertension / CHD / disease / stroke / Heart disease / cardiovascular disease / numerous chronic diseases / coronary heart disease / high blood pressure / /

MedicalTreatment

dietary supplement / dietary supplements / /

Organization

Task Force / Food and Drug Administration / Joint National Committee on Prevention / Detection / Evaluation / and Treatment of High Blood Pressure / Docosahexaenoic Acids and Reduction of Blood Pressure in the General Population CRN1 / American Heart Association / GOED / Federal Trade Commission / Task Force on Consumer Health Information for Better Nutrition / Council for Responsible Nutrition / Global Organization / Environmental Protection Agency / office of Nutritional Products / Labeling and Dietary Supplements / Centers for Disease Control and Prevention / /

Person

Van Elswyk / James C Griffiths / /

Position

General / Vice President / Scientific & International Affairs / /

ProvinceOrState

Maryland / /

Technology

CVD / /

URL

http /

SocialTag